Jay Kulsh has spent three decades pushing for recognition and formal trialling of electrotherapy, a promising avenue for cancer treatment.
An early encounter with a promising and innovative avenue for the treatment of cancer with electricity launched Jay Kulsh on a journey which has occupied three decades – so far. The beauty of his proposed treatment is that it applies to the process of cancer and is therefore not cancer-specific, and potentially of benefit to vast numbers of people. This potential has also proved to be a major obstacle to generating any interest in trialling the concept, as it threatens established financial and reputational interests. Jay has become used to facing closed doors at the very centres where he initially expected the greatest interest, and so has more recently redirected his attention to informing people with cancer directly.
* Please scroll down if you prefer to read the transcription.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Δ
Robin Daly Hello and welcome to the Yes To Life show on UK Health Radio. I’m Robert Daly, host for the show and founder of Yes To Life, the UK charity that’s been advocating for integrated medicine for those with cancer for two decades.
Robin Daly And I’m delighted to be able to report there is some progress in that direction, although not nearly enough, as we’ve been swimming against a strong existing current, going in another direction altogether.
Robin Daly But I think the tide may be finally turning in our favour. My guest today is someone who’s also been swimming against that same current, the current that puts profit ahead of people, for more like three decades, pushing for some interest in a straightforward and credible means to tackle cancers of all type, definitely not something that fits the business plan of the cancer industry.
Robin Daly I’m talking to Jay Kulsh in India. Great to welcome you as my guest on the Yes To Life show. So today we’re going to be speaking about a topic that I have to say, I don’t think it’s ever been a subject of a Yes To Life show in all the last eight years, electrotherapy.
Robin Daly So if you give them just a few minutes to convince someone with cancer that electrotherapy is something they should consider seriously, what would you say to them?
Jay Kulsh Well, in the cancer growth process, the most critical enzyme is this tribodegrutide reductase. It converts the building blocks of RNA into those of DNA. And RNA is used for so many purposes, so those building blocks are always there.
Jay Kulsh Only when cell is ready to divide, then it converts them into DNA for DNA synthesis. And this enzyme is the bottleneck for that. And in any cancer, when you look at the activity of the enzymes, this by far is the most active enzyme.
Jay Kulsh And so, people have been trying to block this enzyme by different chemo drugs. And this has been going on for more than 50 years.
Jay Kulsh but chemo drugs obviously have side effects and they are not able to just selectively block this enzyme. So with this electrotherapy, we are taking advantage of the fact that the enzyme has a free radical that its active site, active site is like a heart.
Jay Kulsh So if you can wedge that free radical, if you can destroy that free radical, then you essentially destroy the enzyme and it doesn’t function anymore. So I came up with the idea that free radical is nothing but unpaired electron and we can quench that electron, destroy that electron or pair up that electron if we pass gentle electric current through the tissue and this was just an idea of mine in 1994.
Jay Kulsh So then I went to look at the cancer research being done in all directions and I found enough anyone studies to affirm that this actually is possible and best results were obtained when they did not use too much current because too much current will cause electrochemistry which is toxic and also it uses up electrons for something else.
Jay Kulsh So the key is to keep the electron voltage low so there’s no electrochemistry and you gently pass the current through the tissue and destroy this this enzyme and every study took then there were about 10 studies were in accordance with my proposition and I published this thing in 1997.
Robin Daly OK, so you’ve come up with a suggestion then for a new approach to something they’ve been trying to do for a long time, using electricity to actually interrupt a process of cancer, as you like, to put a spatter in the works.
Robin Daly And OK, well, look, you’ve covered a lot of ground there quickly, so I’m going to want to go into a lot of what you said in more detail as we go on. But just to talk about your idea as a whole, so you’ve been on and you’re still on a very, very long journey with electrotherapy, something like three decades.
Robin Daly Sadly, this is par for the course for anyone with something new to bring to the table in cancer, new thinking or new clinical experience. You’re far from the first to find this kind of resistance. Just can I ask how you got onto this track in the first place and what were your hopes at the outset?
Jay Kulsh Well, I learned about this enzyme in the late 70s that as a graduate student at the University of California Los Angeles, I got interested because I was an organic chemist, but I wanted to learn or synthesize compounds that have some application to the real world, to the biology.
Jay Kulsh And so I went to biochemistry and I decided to propose a research idea based on the structure of this enzyme. So then that is when I learned about this unique structure of the active side of this enzyme.
Jay Kulsh Right. And later on, I did not finish my PhD, but later on in 1993, I went back to UCLA Medical Library. I lived nearby and I looked through the structure of this enzyme, and in mammalian enzyme also, it turned out to be the structure is same because in the late 70s, it was the only bacterial enzyme that they knew about.
Jay Kulsh Right. So then my first thing, this is surprising, is that this active side of the enzyme is the place where cancer is initiated because I had this idea in late 70s that if you look at the structure of these carcinogenic chemicals, they are uniquely suited to disturb the site.
Jay Kulsh So that was my big hope that the structure remains something consistent and it will be vulnerable to these carcinogenic chemicals. And that is when I wrote an article and I met Dr. James Watson in New York, and at that time, I couldn’t convince him that biochemistry has a role to play in cancer.
Jay Kulsh Right. But later on, he admitted in an article in New York Times in 2016 that biochemistry is where we will most likely find the cause of cancer.
Robin Daly I’ll just go back to James Watson for a second there, very interesting, just so everybody is aware that James Watson, if you like, kick-started the whole research into the genetic side of cancer, and he remained convinced for most of his life that they were going to find the answers there, but as you pointed out, in his late life, he’s turned full circle and said, well, actually, no, we’ve been barking up the wrong tree.
Robin Daly The answers aren’t going to be found there. And what you’ve been saying is that rather than looking into that side of things, you’ve looked into the biology of the cell, you’re looking at what’s going on.
Jay Kulsh I was slightly dissected. Cancer researchers have been focusing on biology of the cell too much. They have to look at the biochemistry of the cell. Biochemistry. Biology is what you see, the effect of the biochemical processes, but you have to look at the biochemistry because it is the chemicals that cause most of the cancer.
Robin Daly Right. Okay. Thanks for clarifying that. That’s good.
Jay Kulsh Most cancer research departments and institutions, they do have a department called biology of cancer, but they do not normally have a department studying biochemistry of cancer, which is what I think is normal.
Robin Daly Okay, interesting. So, anyway, you came along, you basically had a bit of a light bulb moment early on there that told you, look, there’s potential for interrupting the process of cancer in a new way.
Robin Daly I imagine you must have been very fired up, and what were your hopes on the outset?
Jay Kulsh See, in 1993, when I went and met Dr. Watson, at that time, I only had the idea that this is most likely the site where cancer is initiated. But when nobody cared for that, and I couldn’t convince any of the scientists who were working on the enzyme, then I came up with the idea that electricity may destroy this free radical, and thus it will become a method of treatment.
Jay Kulsh And the idea occurred to me because I knew that chemicals cause cancer, but chemicals that are also used to treat cancer. Likewise, variations cause cancer, and they are also used to treat cancer. A very good point.
Jay Kulsh Similarly, electricity at high voltage causes leukemia. So then I said, how about electricity treating cancer? And then it occurred to me, oh, there is a free radical here, so that would be the best way to do it.
Robin Daly Well, it’s very interesting, isn’t it, I mean, it’s obviously it’s a very striking feature of cancer treatments that, you know, the main modalities for two or three of the main long term modalities they use are actually cancer causing approaches, you know, right?
Robin Daly Yeah, chemicals are carcinogens, and people do get cancer from the treatment. And similarly, radiation is and that also causes cancers later on. Right. So yeah, it’s a very interesting observation to make.
Robin Daly And I didn’t know that an electric shock could give you leukemia. That’s a new piece of information, but also very interesting.
Jay Kulsh In fact, in 1992, I read an article in Time magazine that in Sweden, they had to observe that people who live near high voltage electric lines, they have much higher data of leukemia. That is what inspired me to go in January of 1993 to the UCLA Biomedical Laboratory and look into the structure of the enzyme.
Robin Daly Right, how fascinating. Well you set out enthusiastically back in the last century to try and find people to turn your ideas into reality to test them out to find out whether there’s any mileage in them and I’m aware that you’ve made enormous efforts over that time through your theory tested to raise interest and you’ve met largely with a resounding no thanks.
Jay Kulsh Most of the time they just ignore, they don’t want to have that knowledge.
Robin Daly Right. There’s probably too much to tell now, but perhaps you can summarize the avenues you pursued and this has proved to be a dead end. What happened apart from the ones who just ignored you?
Jay Kulsh Yeah. After I had this confirmation that electrotherapy does help in anybody’s studies in 1994, I sent letter to National Gas Institute of USAID, as well as all the top, the so-called comprehensive cancer centers, they were about 10 or 12.
Jay Kulsh I sent them even the top articles which showed the electrotherapy effectiveness and my ideas. Then I did not get response, so I called them. I called them a couple of times. Out of about 12, only three responded.
Jay Kulsh One was at National Gas Institute, and he told me to go to a place called City of Hope Medical Center that is near Los Angeles and talk to somebody who has been working on electricity. That was a big hope.
Jay Kulsh I went there, and there was a Dr. Chow who had gone to China. His method was more like electrochemistry rather than electrotherapy. Still, he had good results in some cases because he didn’t apply to higher voltage.
Jay Kulsh Luckily, there was another scientist there in that City of Hope Medical Center who was working on this enzyme. He totally agreed with me. He agreed with me. This is likely the site of initiation and the gentle electrodes that people block the enzyme.
Jay Kulsh I was elated. I was so happy that day. I imagine. Yeah, but then they said, okay, we are going to set up a collaboration at demand. I waited for that phone call or that letter, but in 10 days when I called them, they said, oh, management doesn’t see any point in pursuing this.
Jay Kulsh This line was it won’t bring patients because they meant patients with big money.
Robin Daly It’s not going to generate income.
Jay Kulsh That has been my big disappointment, and then I did get a letter from MD Anderson Cancer Center, which was also very encouraging. It said that my ideas are very interesting, but pursuing, but they will keep it in their files for some future opportunity.
Jay Kulsh But obviously, that opportunity hasn’t come even now after 30 years.
Robin Daly are still waiting. Amazing. So you mentioned there what is potentially the largest obstacle to interesting new ideas about treating a disease that let’s face it is killing the better of us as a species, is the money.
Robin Daly And it’s not the lack of money to do, is there’s too much money and it’s actually it’s a business and people have a business model they don’t want to threaten with any new ideas.
Jay Kulsh Right and this is as much true in UK as it is in USA because when I was able to publish my articles in 1997 in a journal then I sent that article to about 300 cancer institutions around the globe and in the UK I think there were about eight of them if it can center that I sent that to and seven of them replied which was a very high rate and all of them said we do not have facility to test this and the eighth one who did not reply was actually a center which had done similar studies and I had cited there is study in my article that is the one that you don’t
Robin Daly reply right you thought that was probably the best hope of a lot and they didn’t even reply right
Jay Kulsh And then outside the UK, around the globe, only a company from India replied, and the top cancer institute here called Tata Memorial Center, it replied. And it wanted to collaborate with me. But even they got cold feet within a month.
Jay Kulsh They just changed their mind.
Robin Daly So they, well, you say they changed their mind, but somebody warned them off, basically.
Jay Kulsh what will happen to all the chemotherapy and radiation.
Robin Daly You get some genuine interest from scientists who see potential for your work in regards to their patients, clinicians and scientists who are genuinely interested in helping. And then you have the people who are interested in looking after the business model who have more power, and they all get warned off.
Robin Daly It’s a horrible thing. I noticed you quoted a statement of Upton Sinclair, social reformer and author on your website. It’s difficult to get a man to understand something when his salary depends on his not understanding it.
Robin Daly That is a good quote. It’s unthinkable the totally massive nature of the effect of that one thing on the progress of medicine. It’s just like shocking to think about how much effect it’s having. When you look at yours is one example, I say many, where people have come along with something worthwhile that’s definitely worth investigating.
Robin Daly It doesn’t fit with the model of business that’s going on. And it just gets ignored, frankly.
Jay Kulsh that they talk about disruptive innovation. This is an extreme example of it. Right. I mean, they do not want to face this. It’s like these defense contractors, they do not look forward to a form where there will be total peace.
Jay Kulsh Then what will they do? Right, exactly.
Robin Daly Right, so that’s one of the issues. I think another issue maybe that you’re saddled with is the fact of what we were talking about earlier is that the prevalent model of cancer research is entirely around genes and you’re coming at it from a completely different direction.
Robin Daly How much has that impacted your ability to be heard?
Jay Kulsh Well, that is part of it, but that doesn’t affect the fact that even other cancer researchers, they also try to block chemical pathways, biochemical pathways, so that is not new. Even those who believe that genes cause cancer, they still want to synthesize chemo drugs that block biochemical pathways, so they want to disagree with me that this enzyme is important.
Jay Kulsh Even if it is not the initiation point, but their position is simply because it is going to disrupt too much.
Robin Daly Right, right. Okay, now there’s one thing you mentioned when you were talking about the work had gone on with China. You were talking about two different processes. I just want to distinguish between the two.
Robin Daly You said that in China they were applying higher voltage, and therefore they were in the area of electrochemistry.
Jay Kulsh I mean, I actually there is a there was a Swedish scientist called Robert Strong. Yes He had this idea of treating Casa with electricity and his electricity was around 10 volts Which is and the bike and electrochemistry starts in around 3 volts.
Jay Kulsh Okay, so so obviously with his Strength of electricity the there will be electrochemistry in the body and that was a lot of toxic side effects, right? So but even then he was able to see some benefit in some cases Okay, and that is what that China thing was in in 1993
Robin Daly the fall. I see. So that threshold of three golds, below that there’s one kind of process is going on which doesn’t produce spurious chemistry which has another effect. It just has an effect on electrons but above that you’re into a territory where you’re creating chemistry and therefore the effects are wider and maybe more destructive.
Jay Kulsh Right, right, right. And this three volt is not very exact. It depends on the tissue. And also depends upon where you place the electrode. Because if you are placing electrode on the surface without inserting it in the tissue cell, then you can increase this three volt a little bit higher.
Jay Kulsh I see. So you can go up to six volt because no electrode is touching the medium or so to speak of the tissue. So electrochemistry cannot take place.
Robin Daly Right. Okay. Interesting. All right. Thank you for clearing that up. Just want to be sure what we’re talking about. So on the positive side, I was wondering, well, what have you managed to achieve in 30 years?
Robin Daly And what’s happened that you would describe as a step forward as a success?
Jay Kulsh But the main thing was for me to show that this thing not only works in animal studies, but also with humans. And nobody was willing to, those answer scientists were willing to take on this. So I established a website and I tried to promote this idea.
Jay Kulsh And then the visitors told me to maybe make a device yourself. So I made a very primitive device in 2000 to 2010. And then one person who was an electronic engineer, he built his own device to treat his father-in-law.
Jay Kulsh and he was able to treat it, which you see those photos on my website and then it got me the idea that I should get a device like that. So then I got that device and I came to India in 2010 in the hope that I will have some collaboration with some scientists or some hospitals or clinics here and only one doctor in Agra, the Taj Bell city, was willing to collaborate with me.
Jay Kulsh But even he stopped collaborating when two patients clearly showed benefit.
Robin Daly Right. You were doing better when it didn’t work. I mean, it’s shocking, isn’t it, when you hear this stuff, because it’s, you know, people are literally scared off by the fact that something could just provide a huge step forward and therefore change the model that they’re all working in so radically.
Robin Daly It’s shocking, really, that the fear of the change it will bring is greater than the desire to help people.
Jay Kulsh Yes, from the point of view of cancer patients, it is very unfortunate.
Robin Daly It is more than unfortunate. You’re right. But I mean, I think you and I have both reached the same conclusion that for change to actually happen in oncology, we need to be talking to those with a genuine investment in finding answers, rather than an investment in just looking for answers.
Robin Daly And so I’m referring, of course, to people with cancer. So you started to want to address directly the people who stand to benefit from your ideas. Is that right?
Jay Kulsh Right. That is why from my website, I hope some cancer patients contact me. Most of the time, they contact me. They contact me in a very late stage. At that point, we can only relieve pain. You cannot help much.
Jay Kulsh Recently, this lady in Oregon, which is just north of California, she contacted me last year. She had these two tumors under her lower eyelid. And she was so persistent, she kept using the treatment every day, and it benefited very clear.
Jay Kulsh But after a few months, the benefit is talked. Her two tumors had become one, but we were not seeing any further diminishing in the side. It was not shrinking anymore. Right. And then it occurred to me that most likely the tumor is no longer growing, because if the tumor is not growing, then we don’t have that enzyme.
Jay Kulsh Right. So the natural therapy cannot do much.
Robin Daly Right. It doesn’t need to actually, because it’s not a danger when it’s not growing anymore.
Jay Kulsh Right. So then I suggested to her that if we use needle electrode, then we are going to disturb the tumor and then it should try to grow again and we can shrink it. And she took upon my, I was gingerly suggesting it.
Jay Kulsh Right. And but she took on the idea. She said, send me the needle electrode. And short enough, when she used them, there was some bleeding, but it was good kind of bleeding because bleeding was of the, from the catheter cell.
Jay Kulsh And, and they started shrinking, shrinking and soon it was totally gone. Amazing. And it, but it confirms my proposition that it is the enzyme which is active that we are targeting. This is the enzyme, the free radical.
Robin Daly Right. Okay, I’m going to come back to that again. And just on the whole process you’ve been through, I mean, frankly, it’s quite incredible that you’re still so motivated after 30 years, having generated so little interest from cancer research as a whole.
Robin Daly I mean, what is it that keeps you going?
Jay Kulsh Well, I think this is a big prize. I mean, this is not a simple thing because you keep hearing this thing that cancer is a very complex disease, that it is not one disease, it is a connection of hundreds of diseases.
Jay Kulsh This is the normal thing you hear. Yes. And this is a plea to give more money to cancer researchers. Yes. But my contention is that cancer is really a very simple disease. It looks complicated. It looks many diseases, simply because they are looking from the wrong perspective.
Jay Kulsh It’s just like planetary motion, astronomical. When they thought that it is the earth that is at the center of the motion, then they found the planetary motion very complicated. But once they had the right perspective that it is the sun that is at the center, that all that complexity was gone.
Jay Kulsh Everything became simple and rash.
Robin Daly That’s a great analogy, yes.
Jay Kulsh So I certainly say that this is exactly what is happening here. If we look at the biochemistry of cancer and see that this is the most active enzyme in cancer, if the cancer is initiated here, then really there is no difference whether the cancer isn’t pancreas or it is in your brain or it is in prostate.
Robin Daly it. Yeah, that’s all the same thing. Interesting. Okay, so look, let’s go a little bit into the nuts and bolts of electrotherapy now. So it is quite a complicated concept for many people, I think, but people may just think of it as you trying to electrocute cancer, but it’s actually quite a sophisticated concept.
Robin Daly But there’s some good scientific thinking behind it. Do you want to just tell us again, now we’re going to talk about why electricity has an effect on cancer, what it is exactly the electricity is doing.
Jay Kulsh electricity is a collection of electrons. And electrons are free-flowing electrons, and then we have to look at the chemistry. In the chemistry, all bonds are formed by sharing or exchanging electrons.
Jay Kulsh All chemical bonds are defined by this process, sharing electrons or exchanging electrons. And there is only one exception to that thing, and this is called free radical.
Jay Kulsh Predatical is a chemical compound that doesn’t share or exchange electrons, it just stays there as a lone electron and these chemical compounds are very unstable. So if we combine this chemistry understanding with the fact that electricity is nothing but the flow of electrons, then we can see that if we provide some electrons to this lone electron called free radical, then it is going to pair up with one of those electrons which are passing by,
Robin Daly That’s interesting. So free radicals is something that a lot of people talk about on this show, particularly. So these are undesirable in large prosthesis, they cause damage, and they’re like a sort of wild card wandering around your body with, you know, they’re not properly sort of paired up and therefore stable.
Robin Daly As you say, they’re kind of unstable, and they can cause trouble when they come into contact with other tissues because they have this kind of attraction, like they’re looking, you know, by only having one, a single electron, they’re effectively not paired up until they go in there and cause trouble.
Robin Daly So you’re saying, well, look, we come along, we supply them with the thing that they don’t have, which is another electron to pair up with. And in doing that, we actually neutralize the negativity that they create.
Robin Daly Is that a reasonable picture?
Jay Kulsh Right. I want to add something which is very interesting that free radicals are normally because they’re bad actors and we talk about antioxidants. Antioxidants are good for us because they mop up these wild free radicals.
Jay Kulsh Yes. But recent research has shown and this is I’m going to cite a paper by a lady of MIT biochemist and the person and biochemist of Harvard, they jointly wrote an article in 2021. It is called free radicals in biology.
Jay Kulsh Your life is in their hands. Interesting. Okay. They say that our image of free radicals is at best bad actors, but really this enzyme, what I would need to try to deduct is, has a free radical which acts as a signal.
Jay Kulsh When they say your life in their hands means this, these periodicals also act as triggers, as signals. So this periodical most likely acts as a trigger for cell to divide.
Robin Daly just to be clear of course we need that at times it’s not that we don’t need cells to divide that’s part of the process of life yeah
Jay Kulsh Yeah. Right. But it should be the ugly. Yes.
Robin Daly should be regulated. Okay, interesting distinction. Right, thank you. So it’s a very important process which we need and therefore there’s nothing wrong with it but it’s the regulation of it that goes wrong and then we’re in trouble because things start dividing uncontrollably.
Robin Daly Great. So this is the process you want to interrupt is kind of when this enzyme has gone rogue, if you like, and is acting in a way which is not to our detriment. Right, interesting. So maybe you could just describe what the process looks like practically now.
Robin Daly So you’re saying you’re applying a low voltage electric current directly to the tissue that’s affected. So do you want to tell us what that looks like?
Jay Kulsh Well, if the tumor is inside the skin, we only can treat those tumors which are near the surface because if the tumor is in the liver, then you need a surgeon to plant electrodes there.
Robin Daly but you could treat a liver cancer.
Jay Kulsh It is universal cancer treatment. That also is scary to many of cancer researchers. What we do, the device that we provide, if the tumor is just under the skin, then you have to prepare the skin on top of the tumor so you remove the dead skin cells so the current can flow through that part.
Jay Kulsh Then you place an electrode that I make which is covered in a cloth and under the cloth between the skin, we put the electrode jam so the current can flow easily and it doesn’t burn the skin. We put another electrode on some normal skin surface so that the current flows through the malignant area.
Jay Kulsh If the tumor is large, then we can put both electrodes on the tube. I see. So in case of that lady, there’s a picture of her where the other electrode is on her
Jay Kulsh So one electrode is on top of the tumor other is on the cheek and if there is a need for using needle electrode and obviously that needle electrode has to be inserted only the tip exposed rest insulated in the tumor and other art can be just like before surface electrode.
Robin Daly So you talked about this electronic engineer developing a more sophisticated model than the one you’d made. What did he bring to the table? In what way was it more sophisticated than your own?
Jay Kulsh Yeah, my device was very primitive, because with electronics, you can regulate the current and voltage, because we can say that we want to pass the current at constant voltage. So if that resistance in the body goes down, then the current will be a little bit higher.
Jay Kulsh which is not a problem because we are limiting the voltage. And sometimes when we know how much current we can pass, then we need to pass, then we can just fix that current and let the voltage change, because we know that voltage will not go higher for this range of current, and it may go lower.
Jay Kulsh Let me give an example of my own. I have a prostate cancer for last six years, and I had been treating it, okay, I mean, now and then with my old device, and I always pass 20 milliampere current. And depending on the day, sometimes the voltage is the 2.9, sometimes 2.2.
Jay Kulsh So if the connection is good, it is, I get a 2.2, and that helps me. So I kept my prostate cancer in control by using my own method.
Robin Daly Interesting, so what he produced was a device that allowed for the variations that happen both in the body and in the connection you might have to the body which could be variable.
Jay Kulsh Yeah, that is the beauty of the electronic circuit that when it is told that keep the current at this level and obviously an electronic device, you can also set the time that pass the current for four hours, which is quite a standard.
Jay Kulsh So that is the beauty of it. And then this electronic device is not all that complicated, but still it is a big help because it keeps the current steady or the voltage steady, and it shuts off when the time is over.
Robin Daly All right, excellent. All right, so that leads us on to the question, well, look, if somebody’s listening to the show now, and they’re interested to look into electrotherapy, what do you recommend they do?
Jay Kulsh they can contact me from the website, and I send my device and electrodes all over the globe. I can help them set up things if they have some questions over a web meeting and video meeting, or I can use the phone.
Jay Kulsh Right now, there are two other patients, both also in the USA, who are benefiting from this therapy, and one is a nurse in Arizona. She had a tumor on her head, and it is mostly gone. I would say 80 to 90% gone, but I haven’t posted her pictures yet, so I’m just waiting for her to totally heal.
Jay Kulsh Interestingly, it is this nurse that I dare suggest using needle electrodes. When she used needle electrodes, she got such good results that wrote to me, thank you for suggesting this, and I forwarded that email to that other lady in Oregon, and that got her excited.
Robin Daly that was big help for me. So what you’re saying is that this treatment is safe enough for people to apply it themselves and it doesn’t require specialist care or as long as it’s a tumor that’s on the surface and not internal then it doesn’t need medical experts in order to support
Jay Kulsh But it has to be within a centimeter or so.
Robin Daly Right. Okay. Do you want to give the address of your website so people can have a read?
Jay Kulsh at cancer-treatment.net
Jay Kulsh And they can Google search for the guy named GEIPE.
Robin Daly G-E-I-P-E-S, the name you give to your treatment.
Jay Kulsh Yeah, GE stands for gentle electrotherapy. And I is for in inhibition. PE is for pivotal enzyme. It doesn’t matter whether it is the melanoma or basal cell carcinoma or squamous cell carcinoma.
Jay Kulsh It is the same thing because biochemistry is same. So one of the person in the USA, a man in Alabama, he is treating his melanoma on his leg. Right.
Robin Daly mostly gone. Amazing. Melanom is a tough cookie. So that’s quite interesting to a lot of people I imagine. So look, it’s been a really interesting talk. We’re out of time. There’s lots more we could talk about, but I think we’ve given a fairly good airing.
Robin Daly We’ve heard a lot about it. I sincerely hope in the very near future your efforts are going to be rewarded with a credible study to actually evaluate the efficacy of electrotherapy. But thanks so much for coming on to tell us about it today.
Jay Kulsh I thank you for inviting me. Nice to meet you.
Robin Daly Thanks. Bye-bye.
Robin Daly Well that was fascinating stuff and Jay’s offering to those with cancer certainly sounds like it could be of interest to many people. His website again, cancer-treatment.net, if you want to read more.
Robin Daly Thanks so much for listening today. I’ll be back as usual next week with another Yes To Life show here on UK Health Radio. Goodbye.
We use cookies to improve your experience on our site. Learn more.
We use cookies to enhance your browsing experience and enable essential functions on our website. Some cookies are categorised as "Necessary" are automatically stored on your browser as they are crucial for the basic operation of the site - they can no be adjusted using these tools. Additionally, we use third-party cookies to help us analyse your usage of the website. These cookies are stored in your browser only with your prior consent. You have the option to enable or disable some or all of these cookies.